Traws Pharma, Inc.TRAWNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-24.30M
↓ 13% vs avg
Percentile
P29
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-21.41M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-24.30M | +18.4% |
| 2024 | $-29.79M | -66.0% |
| 2023 | $-17.95M | -10.1% |
| 2022 | $-16.29M | +16.4% |
| 2021 | $-19.49M | +15.6% |
| 2020 | $-23.09M | -10.6% |
| 2019 | $-20.89M | +8.0% |
| 2018 | $-22.70M | +4.7% |
| 2017 | $-23.82M | -50.6% |
| 2016 | $-15.81M | - |